Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells

Blood

Volumn 99, Issue 9, 2002, Pages 3326-3334

  Gray, Christian P ^a,b   Arosio, Paolo ^a,b   Mersey, Peter ^a,b,c  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b UNIVERSITY OF BRESCIA   (Italy)

^c David Maddison Clin Sci Building   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FERRITIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; IRON BINDING PROTEIN; MONOCLONAL ANTIBODY;

ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MELANOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0036565874     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.9.3326     Document Type: Article

References (58)

1. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes
2. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes, impaired response to mitogen-driven stimulation despite T-cell receptor expression
3. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing ζ molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity
4. Impediments to successful immunotherapy
5. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
6. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function
7. Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma
8. In situ analysis of transforming growth factor-beta s (TGFβ 1, TGF-β 2, TGF-β 3), and TGF-beta type II receptor expression in malginant melanoma
9. Melanoma-associated expression of transforming growth factor-β isoforms
10. Immunosuppressive effects of melanoma-derived heavy-chain ferritin are dependent on stimulation of IL-10 production
11. Serum ferritin as a guide to therapy in neuroblastoma
12. On ferritin heterogeneity: Further evidence for heteropolymers
13. Ferritin: Structure, gene regulation, and cellular function in animals, plants, and microorganisms
14. Human ferritin H and L sequences lie on ten different chromosomes
15. A role for ferritin in hematopoiesis and the immune system
16. Ferritinaemia in cancer
17. Structure of gene and pseudogenes of human apoferritin H
18. Suppressive effect of ferritin on in vitro lymphocyte function
19. Differential effect of isolated placental isoferritins on in vitro T-lymphocyte function
20. Activated lymphocytes from breast cancer patients express the characteristic of type 2 helper cells-a possible role for breast cancer-associated p43
21. Reversal of ferritin-mediated immunosuppression by levamisole: A rationale for its application to management of the acquired immune deficiency syndrome (AIDS)
22. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
23. Expression of terminal deoxy-nucleotidyl transferase in myeloblasts
24. Human T-lymphocyte differentiation
25. Characterization of human ferritin H chain synthetized in Escherichia coli
26. Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin
27. TRAIL induces apoptosis in Fas ligand resistant melanoma cells and mediates CD4 T cell killing of target cells
28. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
29. Inhibition of interleukin 2 production by factors released from tumor cells
30. Analysis of flow cytometry data
31. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression
32. + T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific TH1 immune responses
33. T-regulatory 1 cells: A novel subset of CD4+ T cells with immunoregulatory properties
34. Human anergic/suppressive CD4(+)CD25(+) T cells: A highly differentiated and apoptosis-prone population
35. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells
36. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation
37. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
38. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
39. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice
40. CD4(+), CD25(+) T cells as regulators of alloimmune responses
41. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4
42. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class Il-restricted T cells energized in vivo
43. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells
44. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
45. Identification and functional characterization of human CD4+ CD25+ T cells with regulatory properties isolated from peripheral blood
46. Human CD25+ CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function
47. Ex vivo isolation and characterization of CD4+ CD25+ T cells with regulatory properties from human blood
48. Certified professionals: CD4+CD25+ suppressor T cells
49. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance
50. Thymic selection of CD4+ CD25+ regulatory T cells induced by an agonist self-peptide
51. Chronic exposure to superantigen induces regulatory CD4(+) T cells with IL-10-mediated suppressive activity
52. Immature human dendritic cells induce regulatory T cells in vitro
53. IFN-α IL-10 induce the differentiation of human type 1 T regulatory cells
54. T-cell stimulation: An abundance of B7s
55. The expanding world of co-stimulation: The two-signal model revisited
56. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function
57. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
58. PD-L2 is a second ligand for PD-I and inhibits T cell activation